Skip to main content
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2005 May;66(3):172–180. doi: 10.1016/j.curtheres.2005.06.007

Effectiveness and tolerability of once-daily nimesulide versus ibuprofen in pain management after surgical extraction of an impacted third molar: A 24-hour, double-blind, randomized, double-dummy, parallel-group study

Mildred Bocanegra 1,**, Alberto Seijas 2, María González Yibirín 3
PMCID: PMC3964531  PMID: 24672121

Abstract

Background:

Nimesulide is a nonsteroidal, anti-inflammatory drug that hasbeen used for a wide range of acute and chronic pain. A once-daily formulation of nimesulide is now commercially available, but its effectiveness in pain management after dental surgery has not been assessed.

Objective:

The aim of this study was to assess the analgesic effectiveness and tolerability of oral treatment with once-daily nimesulide versus ibuprofen q6h over 24 hours in patients with postoperative pain associated with surgical extraction of an impacted third molar.

Methods:

This 24-hour, double-blind, randomized, double-dummy, parallel-groupstudy was conducted at a private practice in Caracas, Venezuela. Patients aged between 12 and 60 years with moderate to severe pain after extraction of an impacted third molar were enrolled. Patients were randomized to receive a single dose of nimesulide (300-mg tablet) or ibuprofen (400-mg tablets) q6h for 24 hours. For double-dummy design, patients in the nimesulide group also received ibuprofen placebo tablets, to be taken q6h for 24 hours, and patients in the ibuprofen group received a nimesulide placebo tablet. The primary end points were pain intensity (PI) and pain relief scores over 24 hours. Secondary end points included total pain relief, PI difference (PID), sum of PID (SPID), time to first measurable change in PI (ie, PID ≥ 10 mm), and use of rescue medication (acetaminophen). Patients also rated the treatment's effectiveness as very poor to very good on questioning by the study investigator. Spontaneously reported adverse effects (AEs) were recorded.

Results:

Eighty-six patients were enrolled (56 females, 30 males), with 43 patientsper treatment group (mean age: nimesulide group, 25.2 years; ibuprofen group, 24.2 years). The baseline characteristics were statistically similar between the 2 groups. Compared with baseline, mean PI scores were significantly lower in both treatment groups at all time points throughout the study (P < 0.001). Mean PI scores were significantly lower in the nimesulide group compared with the ibuprofen group at 15 and 45 minutes and 1 hour after study drug administration (P ≤ 0.049). Time to first measurable change in PI was within the first 15 minutes in 22 patients (52%) in the nimesulide group and in 14 patients (33%) in the ibuprofen group (P = 0.03). Analgesia lasted 24 hours with nimesulide and ibuprofen (PI scores at 24 hours, 9.4 and 3.6, respectively). The mean PR score was significantly lower in the nimesulide group compared with the ibuprofen group at 1 hour after study drug administration (P = 0.049). Compared with baseline, PID and SPID were significantly higher in both treatment groups throughout the study (P < 0.001). Significantly more patients in the nimesulide group than in the ibuprofen group reported that treatment provided effective pain relief (82% vs 73%; P = 0.013). No AEs were reported in either treatment group throughout the study. Use of rescue medication was statistically similar between the nimesulide and ibuprofen groups (38% and 31%, respectively).

Conclusions:

In this study of patients with moderate to severe pain afterextraction of impacted third molars, nimesulide and ibuprofen provided effective 24-hour relief. However, the results suggest that the analgesic effect of nimesulide had a faster onset (<15 minutes) and was stronger (based on patient opinion) than that of ibuprofen. Both study drugs were well tolerated.

Key words: nimesulide, ibuprofen, dental pain, programmed liberation

Full Text

The Full Text of this article is available as a PDF (532.7 KB).

References

  • 1.Bakshi R., Jacobs L.D., Lehnert S. A double-blind, placebo-controlled trial comparing the analgesic efficacy of two formulations of diclofenac in perioperative dental pain. Curr Ther Res Clin Exp. 1992;52:435–442. [Google Scholar]
  • 2.Malmstrom K., Daniels S., Kotey P. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther. 1999;21:1653–1663. doi: 10.1016/S0149-2918(99)80045-9. [DOI] [PubMed] [Google Scholar]
  • 3.Joshi A., Parara E., Macfarlane T.V. A double-blind randomised controlled clinical trial of the effects of preoperative ibuprofen, diclofenac, paracetamol with codeine and placebo tablets for relief of postoperative pain after removal of impacted third molars. Br J Oral Maxillofac Surg. 2004;42:299–306. doi: 10.1016/j.bjoms.2004.02.004. [DOI] [PubMed] [Google Scholar]
  • 4.Zelenakas K., Fricke J.R., Jr, Jayawardene S., Kellstein D. Analgesic efficacy of single oral doses of lumiracoxib and ibuprofen in patients with postoperative dental pain. Int J Clin Pract. 2004;58:251–256. doi: 10.1111/j.1368-5031.2004.00156.x. [DOI] [PubMed] [Google Scholar]
  • 5.Tool A.T., Verhoeven A.J. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate. Arzneimittelforschung. 1995;45:1110–1114. [PubMed] [Google Scholar]
  • 6.Pochobradsky M.G., Mele G., Beretta A., Montagnani G. Post-marketing survey of nimesulide in the short-term treatment of osteoarthritis. Drugs Exp Clin Res. 1991;17:197–204. [PubMed] [Google Scholar]
  • 7.Taniguchi Y., Ikesue A., Yokoyama K. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm Sci. 1995;1:173–175. [Google Scholar]
  • 8.Walton G.M., Rood J.P., Snowdon A.T., Rickwood D. Ketorolac and diclofenac for postoperative pain relief following oral surgery. Br J Oral Maxillofac Surg. 1993;31:158–160. doi: 10.1016/0266-4356(93)90115-d. [DOI] [PubMed] [Google Scholar]
  • 9.Jung Y.S., Kim D.K., Kim M.K. Onset of analgesia and analgesic efficacy of tramadol/acetaminophen and codeine/acetaminophen/ibuprofen in acute postoperative pain: A single-center, single-dose, randomized, active-controlled, parallel-group study in a dental surgery pain model. Clin Ther. 2004;26:1037–1045. doi: 10.1016/s0149-2918(04)90175-0. [DOI] [PubMed] [Google Scholar]
  • 10.Christensen K.S., Cawkwell G.D. Valdecoxib versus rofecoxib in acute postsurgical pain: Results of a randomized controlled trial. J Pain Symptom Manage. 2004;27:460–470. doi: 10.1016/j.jpainsymman.2004.02.001. [DOI] [PubMed] [Google Scholar]
  • 11.Fricke J., Varkalis J., Zwillich S. Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. Am J Ther. 2002;9:89–97. doi: 10.1097/00045391-200203000-00003. [DOI] [PubMed] [Google Scholar]
  • 12.Bracco P., Debernardi C., Coscia D. Efficacy of rofecoxib and nimesulide in controlling postextraction pain in oral surgery: A randomised comparative study. Curr Med Res Opin. 2004;20:107–112. doi: 10.1185/030079903125002694. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES